Please find enclosed herewith the Notice of the Annual General Meeting for your reference.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genomic Valley Biotech Ltd has submitted the Notice of its Annual General Meeting along with the Annual Report for Financial Year 2024-25 to BSE, as required under Regulation 34 of SEBI's Listing Regulations. The AGM is scheduled for Wednesday, 31st December 2025 at 09:00 A.M. and will be held in physical mode. Soft copies of the Annual Report have been sent electronically to members whose email IDs are registered with the company, depositories, or the Registrar as of the cutoff date of 5th December 2025. The communication is signed by Yogesh Agrawal, Managing Director of the company.
This is a routine compliance filing related to the upcoming AGM and does not carry any direct material impact on the stock price. Shareholders should watch for key resolutions and financial details in the Annual Report that may influence future business direction.